Viatris Expects 2024 Sales Of $14.6B-$15.1B Versus Prior Guidance Of $14.98B-$15.48B And Consensus Of $14.956B
Portfolio Pulse from Benzinga Newsdesk
Viatris has updated its 2024 sales guidance to a range of $14.6 billion to $15.1 billion, down from the previous guidance of $14.98 billion to $15.48 billion. This new range is also slightly below the consensus estimate of $14.956 billion.
August 08, 2024 | 11:12 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Viatris has revised its 2024 sales guidance to $14.6 billion to $15.1 billion, which is lower than its previous guidance and the consensus estimate. This could lead to a negative short-term impact on the stock price.
The downward revision in sales guidance suggests that Viatris may face challenges in achieving its previously expected revenue targets. This could lead to investor concerns and a potential short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100